Treatment of Dementia With Lewy Bodies
Authors:
- 13 November 2013
- journal article
- research article
- Published by Springer Nature in Current Treatment Options in Neurology
- Vol. 15 (6) , 738-764
Abstract
Opinion statement Dementia with Lewy bodies (DLB) is a multisystem disorder with diverse disease expression. A treatment regime restricted to the cognitive aspects of the disease does no favor to patients. Instead, patients should be educated to recognize the symptoms of this multisystem involvement. There are no treatments that slow the progression of disease, but symptomatic treatments can be effective. When thinking about treatment, we find it useful to divide the symptoms and signs into five categories: (a) cognitive features, (b) neuropsychiatric features, (c) motor dysfunction, (d) autonomic dysfunction, and (e) sleep dysfunction. Clinicians, funding bodies and industry are increasingly recognizing the importance of this common and debilitating disease.Keywords
This publication has 114 references indexed in Scilit:
- Risk factors for dementia with Lewy bodiesNeurology, 2013
- Differences in Drug Therapy between Dementia Disorders in the Swedish Dementia Registry: A Nationwide Study of over 7,000 PatientsDementia and Geriatric Cognitive Disorders, 2013
- Donepezil for dementia with Lewy bodies: A randomized, placebo‐controlled trialAnnals of Neurology, 2012
- A Novel Therapy for REM Sleep Behavior Disorder (RBD)Journal of Clinical Sleep Medicine, 2011
- Inclusion of RBD improves the diagnostic classification of dementia with Lewy bodiesNeurology, 2011
- REM sleep behavior disorderAnnals of the New York Academy of Sciences, 2010
- Low sensitivity in clinical diagnoses of dementia with Lewy bodiesJournal of Neurology, 2009
- Massage in the Management of Agitation in Nursing Home Residents with Cognitive ImpairmentGeriatric Nursing, 2009
- Dementia with Lewy bodies: a comparison of clinical diagnosis, FP-CIT single photon emission computed tomography imaging and autopsyJournal of Neurology, Neurosurgery & Psychiatry, 2007
- Effects of Tolterodine, Trospium Chloride, and Oxybutynin on the Central Nervous SystemThe Journal of Clinical Pharmacology, 2001